| 
|  | WH-4-023Chemical Information
    
        
            M.Wt
            568.67
            Storage
            Please store the product under the reco...更多>> |  | 
| 
|  | PP1Chemical Information
    
        
            M.Wt
            281.36
            Storage
            Please store the product under the reco...更多>> |  | 
| 
|  | PP2Chemical Information
    
        
            M.Wt
            301.77
            Storage
            Please store the product under the reco...更多>> |  | 
| 
|  | ImatinibDescription of:ImatinibImatinib (originally STI571) is a drug used to treat certain cancers. It is marketed by Novartis as Gleevec (USA) or Gl...
 更多>> |  | 
| 
|  | DasatinibTheoretical analysis:DasatinibMolecular Formula: C22H28ClN7O3S
 Formula Weight: 506.02082
 CAS No.: 863127-77-9
 A...
 更多>> |  | 
| 
|  | Bafetinib(INNO-406)Description of:Bafetinib(INNO-406)Bafetinib (INNO-406) is an orally available, dual Abl/Lyn kinase inhibitor that is up to 55-times more poten...
 更多>> |  | 
| 
|  | PCI-32765Description of:PCI-32765PCI-32765 is highly active and well tolerated in CLL/SLL pts irrespective of high risk genomic abnormalities. Although...
 更多>> |  | 
| 
|  | BafetinibDescription of:BafetinibBafetinib (INNO-406) is an orally available, dual Abl/Lyn kinase inhibitor (cell IC50 : 11 ~ 22 nM).
 Theoreti...
 更多>> |  | 
| 
|  | Fingolimod(FTY720)Description of:Fingolimod(FTY720)Fingolimod is Src-bcr-Abl Inhibitor & S1P receptor agonist with IC50 of 0.137, 10.98 nM for (S)- and (R)-...
 更多>> |  | 
| 
|  | SaracatinibDescription of:SaracatinibAZD0530 inhibited tumor growth in a manner independent of dose and inhibited phosphorylation of Focal adhesion kinas...
 更多>> |  |